Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-018818
Filing Date
2013-03-28
Accepted
2013-03-28 16:53:09
Documents
1
Period of Report
2013-03-27

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c511748_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c511748_4x0.xml 4 3347
  Complete submission text file 0001209191-13-018818.txt   4814
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Issuer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 5200 ILLUMINA WAY SAN DIEGO CA 92122
Business Address
Posard Matthew L. (Reporting) CIK: 0001543792 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32335 | Film No.: 13724659